Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.Nature Genetics|November 11, 2024
Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancerCarman Man-Chung Li, Alyssa Cordes, Michael U J Oliphant, et al.Nature Communications|October 30, 2025
BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instabilityKathy Situ, Haohui Duan, Stephen K Godin, et al.Cancer Research Communications|July 21, 2025
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular VesiclesJared Sipes, Didi Zha, Sagar Rayamajhi, et al.Cancer Discovery|November 7, 2020
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination ImmunotherapySonia Iyer, Shuang Zhang, Simge Yucel, et al.Research Square|April 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyZoltan Szallasi, Miklos Diossy, Viktoria Tisza, et al.NPJ Precision Oncology|September 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progressionMiklos Diossy, Viktoria Tisza, Hua Li, et al.Nature Reviews. Cancer|April 13, 2026
Rethinking ovarian cancer III: the past decade and future directionsFrances R Balkwill, Céline M Laumont, Nikki Burdett, et al.Pageof 3